Login / Signup

Issues with reporting and interpretation of Khan et al. 2021.

Nicholas J DeVitoHenry Drysdale
Published in: BMC infectious diseases (2022)
A recent publication in BMC Infectious Diseases concerning the use of convalescent plasma for the treatment of COVID-19 had a number of major issues. This correspondence details specific instances of unclear reporting as well as major omissions when discussing the context of the trial. These render the study's findings and conclusions misleading.
Keyphrases
  • infectious diseases
  • coronavirus disease
  • sars cov
  • adverse drug
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase iii
  • emergency department
  • combination therapy
  • electronic health record
  • drug induced